- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05576233
• Comparison of Blood Culture Contamination Rates
Comparison of Blood Culture Contamination Rates Between the Use of Povidine Iodine/Alcohol for Skin Antisepsis and the Use of Chlorhexidine/Alcohol (ChloraPrep) for Skin Antisepsis: An Open-label, Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Detection of the pathogen in blood cultures as soon as possible reduces mortality significantly by providing timely initiation of treatment1. However, when skin antisepsis is not performed properly, an increase in the rate of contamination is observed. In this study, it was planned to compare the contamination rate of two antiseptics, povidine iodine/alcohol and Chlorhexidine/alcohol used as skin antisepsis, in the blood culture taken.
Full randomization" will be applied in the study. Multiples of 3 of the patients to be included in the study will be included in the "Chloraprep" group, the remaining patients and multiples of 2 will be included in the "povidine/iodine" group. . According to the number of samples determined for each institution, patients who came to the outpatient clinic during data collection and accepted to participate in the study will be randomly selected.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients who will be hospitalized at SBU Izmir Dr. Patients who are hospitalized in the Pediatric Infection Service of Behçet Uz Pediatrics and Surgery Training and Research Hospital, and who will require blood culture indications will participate in the study If they are willing to
Exclusion Criteria:
- The patents with central lines will be excluded.
- The patient who were transferred from ICU's will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1.The culture taken after disinfection with providing/iodine
1.Blood cultures routinely performed with alcohol/povidine-iodine
|
lood cultures can be routinely performed with alcohol/povidine-iodine or alcohol/chlorhexidine.
The topical disinfectants used in the two applications are the topical disinfectants included in the guidelines and currently applied in our hospital.
|
Active Comparator: 2.The culture taken after disinfection with chlorhexidine/alcohol
2. Blood cultures routinely performed with chlorhexidine/alcohol
|
lood cultures can be routinely performed with alcohol/povidine-iodine or alcohol/chlorhexidine.
The topical disinfectants used in the two applications are the topical disinfectants included in the guidelines and currently applied in our hospital.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Contamination
Time Frame: 14 days
|
The primary endpoint of the study was to reduce the rate of contamination in blood cultures.
|
14 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- skin antisepsis study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Culture Contamination
-
Shaare Zedek Medical CenterCompleted
-
Shaare Zedek Medical Center3M; Magnolia Medical Technologies, Inc.UnknownPreventing Blood Culture Contamination
-
Central Hospital, Nancy, FranceCompletedBacteremia | Contamination | Blood Culture ContaminationFrance
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationAntibiotic Stewardship | Implementation Science | Blood Culture RatesUnited States
-
Dr Riccardo PaceCompletedBlood Contamination of Root Canal During Endodontic TherapyItaly
-
Dr Riccardo PaceCompletedBlood Contamination of Root Canal During Endodontic Therapy
-
Travis CallahanCompletedUrine ContaminationUnited States
-
University of Sao PauloAstraZenecaUnknownDrug ContaminationBrazil
-
University of Maryland, BaltimoreCompletedBacterial Contamination
-
Ibn Sina HospitalBanoon IVF CenterCompleted
Clinical Trials on disinfection of the surface that the blood culture is taken
-
Centre Hospitalier Universitaire DijonCompleted
-
University Hospital, AngersRecruitingDevelopment Delay | Cancer Childhood | Predisposition, GeneticFrance, Réunion
-
Centre Hospitalier Universitaire de NiceCompletedChronic Kidney DiseaseFrance
-
Zeynep YurdakulUnknown
-
Shenzhen People's HospitalRecruitingChronic Heart Failure With Reduced Ejection FractionChina
-
Centre Hospitalier Universitaire, AmiensRecruitingMortality | Septic Shock | Acute Kidney Injury | Uremic; ToxemiaFrance
-
Achros Health Technologies CorporationUnknownCritical Illness | Mechanical VentilationHungary
-
Abiomed Inc.UnknownChronic Heart FailureCanada
-
Centenario Hospital Miguel HidalgoCompletedKidney Transplant Infection | Asymptomatic BacteriuriaMexico
-
ImagiRation, LLCCompletedAutistic Disorder | Autism | ASDUnited States